Jove
Visualize
Contact Us
JoVE
x logofacebook logolinkedin logoyoutube logo
ABOUT JoVE
OverviewLeadershipBlogJoVE Help Center
AUTHORS
Publishing ProcessEditorial BoardScope & PoliciesPeer ReviewFAQSubmit
LIBRARIANS
TestimonialsSubscriptionsAccessResourcesLibrary Advisory BoardFAQ
RESEARCH
JoVE JournalMethods CollectionsJoVE Encyclopedia of ExperimentsArchive
EDUCATION
JoVE CoreJoVE BusinessJoVE Science EducationJoVE Lab ManualFaculty Resource CenterFaculty Site
Terms & Conditions of Use
Privacy Policy
Policies

Filters

Griffioen

Showing results (661-670 of 873) with videos related to

Pageof 88
Sort By:
Vaccine|March 15, 2025
Targeting the early life stages of SARS-CoV-2 using a multi-peptide conjugate vaccineLauren Myburgh, Haiko Karsjens, Athanasios Blanas, et al.
Lancet (London, England)|December 9, 1989
Presymptomatic diagnosis of familial adenomatous polyposis by bridging DNA markersC M Tops, J T Wijnen, G Griffioen, et al.
Translational Psychiatry|March 1, 2023
Translatability of preclinical to early clinical tolerable and pharmacologically active dose ranges for central nervous system active drugsGuilherme S Ferreira, Francis M Dijkstra, Désirée H Veening-Griffioen, et al.
Cancer Research|May 3, 2003
Tumor angiogenesis modulates leukocyte-vessel wall interactions in vivo by reducing endothelial adhesion molecule expressionAnita E M Dirkx, Mirjam G A Oude Egbrink, Marijke J E Kuijpers, et al.
International Journal of Cancer|April 3, 2003
Vascular targeting effect of combretastatin A-4 phosphate dominates the inherent angiogenesis inhibitory activityBisan Ahmed, Loes I Van Eijk, Jessica C A Bouma-Ter Steege, et al.
Journal of Neurochemistry|May 12, 2010
TLR2 activation inhibits embryonic neural progenitor cell proliferationEitan Okun, Kathleen J Griffioen, Tae Gen Son, et al.
BMC Cancer|July 25, 2012
Stereotactic ablative radiotherapy for comprehensive treatment of oligometastatic tumors (SABR-COMET): study protocol for a randomized phase II trialDavid A Palma, Cornelis J A Haasbeek, George B Rodrigues, et al.
Clinical Cancer Research : an Official Journal of the American Association for Cancer Research|June 13, 2002
Prognostic significance of metallothionein in human gastrointestinal cancerA Miranda L Janssen, Wim van Duijn, Frank J G M Kubben, et al.
Cancer Immunology, Immunotherapy : CII|January 12, 2022
Vaccination against galectin-1 promotes cytotoxic T-cell infiltration in melanoma and reduces tumor burdenJulia Femel, Luuk van Hooren, Melanie Herre, et al.
International Journal of Molecular Sciences|August 7, 2021
Effects of Cancer Presence and Therapy on the Platelet ProteomeMaudy Walraven, Siamack Sabrkhany, Jaco C Knol, et al.
Pageof 88

Showing results (661-670 of 873) with videos related to

Sort By:
Pageof 88
Vaccine|March 15, 2025
Targeting the early life stages of SARS-CoV-2 using a multi-peptide conjugate vaccineLauren Myburgh, Haiko Karsjens, Athanasios Blanas, et al.
Lancet (London, England)|December 9, 1989
Presymptomatic diagnosis of familial adenomatous polyposis by bridging DNA markersC M Tops, J T Wijnen, G Griffioen, et al.
Translational Psychiatry|March 1, 2023
Translatability of preclinical to early clinical tolerable and pharmacologically active dose ranges for central nervous system active drugsGuilherme S Ferreira, Francis M Dijkstra, Désirée H Veening-Griffioen, et al.
Cancer Research|May 3, 2003
Tumor angiogenesis modulates leukocyte-vessel wall interactions in vivo by reducing endothelial adhesion molecule expressionAnita E M Dirkx, Mirjam G A Oude Egbrink, Marijke J E Kuijpers, et al.
International Journal of Cancer|April 3, 2003
Vascular targeting effect of combretastatin A-4 phosphate dominates the inherent angiogenesis inhibitory activityBisan Ahmed, Loes I Van Eijk, Jessica C A Bouma-Ter Steege, et al.
Journal of Neurochemistry|May 12, 2010
TLR2 activation inhibits embryonic neural progenitor cell proliferationEitan Okun, Kathleen J Griffioen, Tae Gen Son, et al.
BMC Cancer|July 25, 2012
Stereotactic ablative radiotherapy for comprehensive treatment of oligometastatic tumors (SABR-COMET): study protocol for a randomized phase II trialDavid A Palma, Cornelis J A Haasbeek, George B Rodrigues, et al.
Clinical Cancer Research : an Official Journal of the American Association for Cancer Research|June 13, 2002
Prognostic significance of metallothionein in human gastrointestinal cancerA Miranda L Janssen, Wim van Duijn, Frank J G M Kubben, et al.
Cancer Immunology, Immunotherapy : CII|January 12, 2022
Vaccination against galectin-1 promotes cytotoxic T-cell infiltration in melanoma and reduces tumor burdenJulia Femel, Luuk van Hooren, Melanie Herre, et al.
International Journal of Molecular Sciences|August 7, 2021
Effects of Cancer Presence and Therapy on the Platelet ProteomeMaudy Walraven, Siamack Sabrkhany, Jaco C Knol, et al.
Pageof 88